Decipher Biosciences, Inc. (DECI)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	33.26M
Net Income (ttm)	n/a
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DECI

Decipher Biosciences is a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers. Our novel prostate cancer genomic testing products, Decipher Biopsy and Decipher RP, provide valuable information about the underlying biology of a patient’s tumor, assisting physicians in their selection of an optimal therapy. Our differentiated approach measures the biological activity of a patient’s entire tumor genome, known as whole transcriptome analysis, and...

• Industry: Medical Devices
• Sector: Biotechnology
• Founded: 2008
• Employees: 95
• Stock Exchange: NASDAQ
• Ticker Symbol: DECI
• Website: https://decipherbio.com/